JANE STREET GROUP, LLC - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 41 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$734,157
+195.7%
88,240
+241.1%
0.00%
Q4 2022$248,314
+110.4%
25,866
+78.3%
0.00%
Q3 2022$118,000
-33.3%
14,507
-40.2%
0.00%
Q2 2021$177,000
+6.6%
24,278
+22.0%
0.00%
Q2 2020$166,00019,8960.00%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Solas Capital Management, LLC 867,857$6,327,0004.44%
Sonic Fund II, L.P. 2,433,230$17,738,0001.31%
DG Capital Management, LLC 588,773$4,292,0000.93%
Southpoint Capital Advisors LP 4,077,214$29,723,0000.52%
HARBERT FUND ADVISORS, INC. 120,851$881,0000.49%
683 Capital Management, LLC 1,110,000$8,091,0000.28%
Avoro Capital Advisors LLC 1,670,000$12,174,0000.21%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 40,000$292,0000.16%
Tibra Equities Europe Ltd 46,300$338,0000.10%
GSA CAPITAL PARTNERS LLP 68,724$501,0000.06%
View complete list of FENNEC PHARMACEUTICALS INC shareholders